Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Duan

Showing results (161-170 of 235) with videos related to

Pageof 24
Sort By:
Molecular Cancer Therapeutics|December 7, 2002
Design and synthesis of fluoroquinophenoxazines that interact with human telomeric G-quadruplexes and their biological effectsW Duan, A Rangan, H Vankayalapati, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituentsGregory R Ott, Naoyuki Asakawa, Zhonghui Lu, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE)Gregory R Ott, Naoyuki Asakawa, Zhonghui Lu, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2008
Alpha,Beta-cyclic-beta-benzamido hydroxamic acids: Novel oxaspiro[4.4]nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)Gregory R Ott, Naoyuki Asakawa, Rui-Qin Liu, et al.
Genetics and Molecular Research : GMR|October 6, 2015
Male-specific association of the APC rs383830 T allele with the risk of coronary heart diseaseJ Y Zhong, X W Zheng, H D Ye, et al.
Zhonghua Nei Ke Za Zhi|April 1, 2016
[The prevalence and etiology of anemia in urban community dwelling elderly population in Beijing]S Y Ning, N B Chang, X Y Han, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 31, 2017
[Risk-factor analysis of poor graft function after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia]C Y Shi, Z H Mamal, X X Liu, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identificationChu-Biao Xue, Xiaohua He, John Roderick, et al.
Journal of Medical Genetics|August 3, 2004
Positive association of the DIO2 (deiodinase type 2) gene with mental retardation in the iodine-deficient areas of ChinaT-W Guo, F-C Zhang, M-S Yang, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2007
Discovery of beta-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitorsJames J-W Duan, Lihua Chen, Zhonghui Lu, et al.
Pageof 24

Showing results (161-170 of 235) with videos related to

Sort By:
Pageof 24
Molecular Cancer Therapeutics|December 7, 2002
Design and synthesis of fluoroquinophenoxazines that interact with human telomeric G-quadruplexes and their biological effectsW Duan, A Rangan, H Vankayalapati, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituentsGregory R Ott, Naoyuki Asakawa, Zhonghui Lu, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE)Gregory R Ott, Naoyuki Asakawa, Zhonghui Lu, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2008
Alpha,Beta-cyclic-beta-benzamido hydroxamic acids: Novel oxaspiro[4.4]nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)Gregory R Ott, Naoyuki Asakawa, Rui-Qin Liu, et al.
Genetics and Molecular Research : GMR|October 6, 2015
Male-specific association of the APC rs383830 T allele with the risk of coronary heart diseaseJ Y Zhong, X W Zheng, H D Ye, et al.
Zhonghua Nei Ke Za Zhi|April 1, 2016
[The prevalence and etiology of anemia in urban community dwelling elderly population in Beijing]S Y Ning, N B Chang, X Y Han, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 31, 2017
[Risk-factor analysis of poor graft function after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia]C Y Shi, Z H Mamal, X X Liu, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identificationChu-Biao Xue, Xiaohua He, John Roderick, et al.
Journal of Medical Genetics|August 3, 2004
Positive association of the DIO2 (deiodinase type 2) gene with mental retardation in the iodine-deficient areas of ChinaT-W Guo, F-C Zhang, M-S Yang, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2007
Discovery of beta-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitorsJames J-W Duan, Lihua Chen, Zhonghui Lu, et al.
Pageof 24